TRICIDA

Mark For: TRICIDA® trademark registration is intended to cover the categories of a house mark for pharmaceutical preparations for the treatment of metabolic acidosis associated with chronic kidney disease; a house mark for pharmaceutical preparations for the treatment of renal diseases and disorders; a house mark for pharmaceutical preparations for increasing bicarbonate levels; a house mark for non- absorbed pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of metabolic acidosis and renal disorders; a house mark for polymeric pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of metabolic acidosis and renal disorders. [all]

Status

2020-06-23 UTC
⟳ Refresh

LIVE APPLICATION Under Examination

Research	OneLook Acronym Finder
Serial Number	87931649
Registration Number	6653958
Mark Literal Elements	TRICIDA
Mark Drawing Type	4 - STANDARD CHARACTER MARK
Mark Type	TRADEMARK
Register	PRINCIPAL
Current Location	PETITIONS OFFICE 2020-06-18
Basis	1(b)
Class Status	ACTIVE
Primary US Classes	006: Chemicals and Chemical Compositions 018: Medicines and Pharmaceutical Preparations 044: Dental, Medical and Surgical Appliances 046: Foods and Ingredients of Foods 051: Cosmetics and Toilet Preparations 052: Detergents and Soaps
Primary International Class	005 - Primary Class (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed Use	No
Current Use	No
Intent To Use	Yes
Filed ITU	Yes
44D Filed	No
44E Current	No
66A Current	No
Current Basis	No
No Basis	No
Attorney Name	Katherine A. Keating
Attorney Docket Number	1080298.67
Law Office Assigned	L50
Employee Name	SHINER, MARK W

Timeline

IC 005. US 006 018 044 046 051 052. G & S: A house mark for pharmaceutical preparations for the treatment of metabolic acidosis associated with chronic kidney disease; a house mark for pharmaceutical preparations for the treatment of renal diseases and disorders; a house mark for pharmaceutical preparations for increasing bicarbonate levels; a house mark for non- absorbed pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of metabolic acidosis and renal disorders; a house mark for polymeric pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of metabolic acidosis and renal disorders